Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of CHILD-IVITAB vs STROMECTOL in Healthy Adults
NCT05477810Phase 1Completed
- Sponsor
- University Children's Hospital Basel
- Start
- Sep 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ivermectin in strongyloidiasis and onchocerciasis (2 arms), sponsored by University Children's Hospital Basel. Primary endpoint: Pharmacokinetics (AUC, Cmax, tmax). Started Sep 2022; status: completed.
02
Drugs
ivermectin
03
Conditions
strongyloidiasisonchocerciasis
Beyond the preview
Go deeper on NCT05477810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05477810.